Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts
暂无分享,去创建一个
[1] D. Bouros,et al. Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population , 2020, Expert review of respiratory medicine.
[2] X. Y. Yang,et al. [Whole exome sequencing and analysis of a Chinese family with familial pulmonary sarcoidosis]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[3] Xin Li,et al. Arsenic induces mTOR-dependent autophagy, whereas it impairs the autophagy-lysosome pathway and the potential role of TFEB in cultured dendritic cells. , 2020, Metallomics : integrated biometal science.
[4] R. Guleria,et al. MicroRNAs in pulmonary sarcoidosis: A systematic review. , 2020, Respiratory investigation.
[5] V. Cottin,et al. [Diagnostic difficulties of chronic pulmonary berylliosis in France]. , 2020, Revue des maladies respiratoires.
[6] S. Atif,et al. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease , 2020, Frontiers in Immunology.
[7] M. Iannuzzi,et al. Genome-Wide Association Study of Ocular Sarcoidosis Confirms HLA Associations and Implicates Barrier Function and Autoimmunity in African Americans , 2020, Ocular immunology and inflammation.
[8] T. Weichhart,et al. Sarcoidosis and the mTOR, Rac1, and Autophagy Triad. , 2020, Trends in immunology.
[9] Rajeev K. Varshney,et al. Fine mapping and gene cloning in the post-NGS era: advances and prospects , 2020, Theoretical and Applied Genetics.
[10] P. Manque,et al. Implications of Selective Autophagy Dysfunction for ALS Pathology , 2020, Cells.
[11] L. Churilov,et al. Sarcoidosis as an Autoimmune Disease , 2020, Frontiers in Immunology.
[12] I. Jonkers,et al. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era , 2020, Open Biology.
[13] M. Lokki,et al. Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis Prognosis , 2019, Frontiers in Immunology.
[14] L. Alfredsson,et al. A Gene–Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis , 2019, Scientific Reports.
[15] B. Kostov,et al. Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants. , 2019, Clinical and experimental rheumatology.
[16] S. Pinson,et al. Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis , 2019, European Respiratory Journal.
[17] N. Barnich,et al. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD , 2019, Autophagy.
[18] J. Grunewald,et al. Sarcoidosis , 2019, Nature Reviews Disease Primers.
[19] S. Akira,et al. Phosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response , 2019, The Journal of experimental medicine.
[20] Kenny Q. Ye,et al. Genetic Variants Associated with FDNY WTC-Related Sarcoidosis , 2019, International journal of environmental research and public health.
[21] J. Taunton,et al. MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis. , 2019, JCI insight.
[22] L. Grossman,et al. HIF-1α regulates IL-1β and IL-17 in sarcoidosis , 2019, eLife.
[23] M. Rosenbach,et al. Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera , 2019, JAAD case reports.
[24] D. Maucort-Boulch,et al. BTNL2 gene polymorphism and sarcoid uveitis , 2019, British Journal of Ophthalmology.
[25] C. van Moorsel,et al. Clinical epidemiology of familial sarcoidosis: A systematic literature review. , 2019, Respiratory medicine.
[26] B. King,et al. Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis , 2018, The New England journal of medicine.
[27] Hara Kang,et al. Hypoxia‐induced regulation of mTOR signaling by miR‐7 targeting REDD1 , 2018, Journal of cellular biochemistry.
[28] S. Akira,et al. Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism , 2018, Proceedings of the National Academy of Sciences.
[29] A. Franke,et al. Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis , 2018, Human Genetics.
[30] S. Chi,et al. XAF1 forms a positive feedback loop with IRF-1 to drive apoptotic stress response and suppress tumorigenesis , 2018, Cell Death & Disease.
[31] J. Grunewald,et al. Familial aggregation and heritability of sarcoidosis: a Swedish nested case−control study , 2018, European Respiratory Journal.
[32] J. Todd,et al. Approaches and advances in the genetic causes of autoimmune disease and their implications , 2018, Nature Immunology.
[33] A. Alcamí,et al. Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation , 2018, Nature Communications.
[34] A. Fontenot. Immunologic Effects of Beryllium Exposure , 2018, Annals of the American Thoracic Society.
[35] V. Besnard,et al. G908R NOD2 variant in a family with sarcoidosis , 2018, Respiratory Research.
[36] J. Bernaudin,et al. Whole exome sequencing in three families segregating a pediatric case of sarcoidosis , 2018, BMC Medical Genomics.
[37] Greg M. Delgoffe,et al. IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation. , 2018, Cell reports.
[38] P. Mota,et al. Associations between sarcoidosis clinical course and ANXA11 rs1049550 C/T, BTNL2 rs2076530 G/A, and HLA class I and II alleles , 2018, The clinical respiratory journal.
[39] A. Choi,et al. Autophagy and inflammation in chronic respiratory disease , 2018, Autophagy.
[40] S. Davoudi,et al. Association of genetic variants in RAB23 and ANXA11 with uveitis in sarcoidosis , 2018, Molecular vision.
[41] Iannis E. Adamopoulos,et al. Structural Activation of Pro‐inflammatory Human Cytokine IL‐23 by Cognate IL‐23 Receptor Enables Recruitment of the Shared Receptor IL‐12R&bgr;1 , 2018, Immunity.
[42] W. Drake,et al. Genetic, Immunologic, and Environmental Basis of Sarcoidosis. , 2017, Annals of the American Thoracic Society.
[43] David C. Thomas,et al. The phagocyte respiratory burst: Historical perspectives and recent advances. , 2017, Immunology letters.
[44] E. Louis,et al. CCDC88B is required for pathogenesis of inflammatory bowel disease , 2017, Nature Communications.
[45] Ming-Hsi Wang,et al. Crohn's Disease: Genetics Update. , 2017, Gastroenterology clinics of North America.
[46] A. Prasse,et al. Transcriptome profiles in sarcoidosis and their potential role in disease prediction , 2017, Current opinion in pulmonary medicine.
[47] P. Visscher,et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.
[48] R. Pique-Regi,et al. RNA-sequencing Identifies Novel Pathways in Sarcoidosis Monocytes , 2017, Scientific Reports.
[49] Robert H. Brown,et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis , 2017, Science Translational Medicine.
[50] V. Anttila,et al. SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility—A Joint Analysis in Four European Populations , 2017, Front. Immunol..
[51] Jun Sun,et al. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation , 2017, Oncotarget.
[52] J. Hugot,et al. Nod2: The intestinal gate keeper , 2017, PLoS pathogens.
[53] M. V. van Vugt,et al. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy , 2017, Autophagy.
[54] Li-qiang Zheng,et al. Rab23’s genetic structure, function and related diseases: a review , 2017, Bioscience reports.
[55] J. Garcia,et al. Annexin A11 is associated with pulmonary fibrosis in African American patients with sarcoidosis. , 2016, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[56] Wolfram Weckwerth,et al. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression , 2016, Nature Immunology.
[57] M. Elsensohn,et al. Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort , 2016, Orphanet Journal of Rare Diseases.
[58] T. Yoshimoto,et al. Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family , 2016, Front. Immunol..
[59] Chuan Wu,et al. Tiam1/Rac1 complex controls Il17a transcription and autoimmunity , 2016, Nature Communications.
[60] Ralf Herwig,et al. Analyzing and interpreting genome data at the network level with ConsensusPathDB , 2016, Nature Protocols.
[61] S. Vermeire,et al. Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? , 2016, Journal of Crohn's & colitis.
[62] M. Diao,et al. The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review. , 2016, Sarcoidosis Vasculities and Diffuse Lung Diseases.
[63] H. Deng,et al. In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway , 2016, Endocrine.
[64] H. Fan,et al. The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility , 2016, Medicine.
[65] N. Prescott,et al. Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis , 2016, Inflammatory bowel diseases.
[66] Lishuang Shen,et al. NOD2 genetic variants and sarcoidosis-associated uveitis☆ , 2016, American journal of ophthalmology case reports.
[67] H. Jiao,et al. Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage , 2016, PloS one.
[68] Jin-young Shin,et al. Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function* , 2016, The Journal of Biological Chemistry.
[69] M. Mirsaeidi,et al. Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis , 2016, Journal of Translational Medicine.
[70] U. Pleyer,et al. Sirolimus for the treatment of noninfectious uveitis , 2016, Expert opinion on pharmacotherapy.
[71] K. Amber,et al. TNF‐α: a treatment target or cause of sarcoidosis? , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[72] M. Iannuzzi,et al. Role of NOD2 Pathway Genes in Sarcoidosis Cases with Clinical Characteristics of Blau Syndrome. , 2015, American journal of respiratory and critical care medicine.
[73] C. Gieger,et al. Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk. , 2015, American journal of respiratory and critical care medicine.
[74] B. Rybicki,et al. Granuloma genes in sarcoidosis: what is new? , 2015, Current opinion in pulmonary medicine.
[75] M. Iannuzzi,et al. Fine mapping of chromosome 15q25 implicates ZNF592 in neurosarcoidosis patients , 2015, Annals of clinical and translational neurology.
[76] M. Suchánková,et al. TREM-2 Receptor Expression Increases with 25(OH)D Vitamin Serum Levels in Patients with Pulmonary Sarcoidosis , 2015, Mediators of inflammation.
[77] F. Song,et al. Intracellular calcium signaling regulates autophagy via calcineurin-mediated TFEB dephosphorylation , 2015, Autophagy.
[78] Q. Al-Awqati. Kidney growth and hypertrophy: the role of mTOR and vesicle trafficking. , 2015, The Journal of clinical investigation.
[79] A. Kijlstra,et al. Genetic variations of IL17F and IL23A show associations with Behçet's disease and Vogt-Koyanagi-Harada syndrome. , 2015, Ophthalmology.
[80] M. Iannuzzi,et al. Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans. , 2014, American journal of respiratory cell and molecular biology.
[81] M. Lathrop,et al. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation , 2014, The Journal of experimental medicine.
[82] J. Ninomiya-Tsuji,et al. Activated Macrophage Survival Is Coordinated by TAK1 Binding Proteins , 2014, PloS one.
[83] N. Ruddle. Lymphotoxin and TNF: how it all began-a tribute to the travelers. , 2014, Cytokine & growth factor reviews.
[84] A. Gabrielsen,et al. HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis. , 2014, Tissue antigens.
[85] M. Iannuzzi,et al. Admixture Fine-Mapping in African Americans Implicates XAF1 as a Possible Sarcoidosis Risk Gene , 2014, PloS one.
[86] E. Hoitsma,et al. Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis , 2014, European Respiratory Journal.
[87] Y. Wu,et al. Regulation of autophagy by the Rab GTPase network , 2014, Cell Death and Differentiation.
[88] I. Surakka,et al. Major histocompatibility complex class II and BTNL2 associations in sarcoidosis , 2013, European Respiratory Journal.
[89] R. Baughman,et al. Calcium and vitamin D metabolism in sarcoidosis. , 2013, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[90] Freddy Radtke,et al. Regulation of innate and adaptive immunity by Notch , 2013, Nature Reviews Immunology.
[91] Y. Iwakura,et al. Negative feedback on IL-23 exerted by IL-17A during pulmonary inflammation , 2013, Innate immunity.
[92] I. Adzhubei,et al. Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.
[93] C. Gieger,et al. A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1. , 2012, American journal of respiratory and critical care medicine.
[94] M. Iannuzzi,et al. Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans , 2012, Genes and Immunity.
[95] Jessica J. Hale,et al. Genome-Wide Association Study of African and European Americans Implicates Multiple Shared and Ethnic Specific Loci in Sarcoidosis Susceptibility , 2012, PloS one.
[96] R. Tampé,et al. Direct evidence that the N-terminal extensions of the TAP complex act as autonomous interaction scaffolds for the assembly of the MHC I peptide-loading complex , 2012, Cellular and Molecular Life Sciences.
[97] B. Horwitz,et al. Nfkb1 Inhibits LPS-Induced IFN-β and IL-12 p40 Production in Macrophages by Distinct Mechanisms , 2012, PloS one.
[98] M. Qiao,et al. The XAF1 tumor suppressor induces autophagic cell death via upregulation of Beclin-1 and inhibition of Akt pathway. , 2011, Cancer letters.
[99] Prescott G Woodruff,et al. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. , 2011, American journal of respiratory and critical care medicine.
[100] B. Charreau,et al. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. , 2011, Biochemical pharmacology.
[101] Justine R. Smith,et al. Association of Interleukin 23 Receptor Gene with Sarcoidosis , 2011, Disease markers.
[102] Y. Zhang,et al. Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects. , 2011, Human immunology.
[103] A. Schuldt. Cell growth: RAC1 sizes up mTOR , 2011, Nature Reviews Molecular Cell Biology.
[104] P. Rosenstiel,et al. A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1 , 2011, European Respiratory Journal.
[105] P. Spagnolo,et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. , 2010, Human molecular genetics.
[106] B. Ryffel,et al. Limited Role for Lymphotoxin α in the Host Immune Response to Mycobacterium tuberculosis , 2010, The Journal of Immunology.
[107] P. Spagnolo,et al. CC chemokine receptor 5 gene polymorphisms in beryllium disease , 2010, European Respiratory Journal.
[108] I. Kockum,et al. Major histocompatibility complex class II transactivator gene polymorphism: associations with Löfgren's syndrome. , 2010, Tissue antigens.
[109] J. Grunewald. Review: role of genetics in susceptibility and outcome of sarcoidosis. , 2010, Seminars in respiratory and critical care medicine.
[110] Nicolas Levy,et al. CAMOS, a nonprogressive, autosomal recessive, congenital cerebellar ataxia, is caused by a mutant zinc-finger protein, ZNF592 , 2010, European Journal of Human Genetics.
[111] S. Biswal,et al. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke – induced pulmonary injury and emphysema , 2010, Nature Medicine.
[112] H. Rammensee,et al. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. , 2009, Clinical immunology.
[113] D. Cutler,et al. Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. , 2009, The Journal of investigative dermatology.
[114] R. Elashoff,et al. Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis , 2009, Fibrogenesis & tissue repair.
[115] G. McLennan,et al. HLA and environmental interactions in sarcoidosis. , 2008, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[116] A. Nebel,et al. Genetics of Sarcoidosis , 2014, Seminars in Respiratory and Critical Care Medicine.
[117] P. Rosenstiel,et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis , 2008, Nature Genetics.
[118] V. Backer,et al. Heredity in sarcoidosis: a registry-based twin study , 2008, Thorax.
[119] B. Ghosh,et al. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)‐α levels in Asian Indians , 2007, Clinical and experimental immunology.
[120] R. Elston,et al. Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study , 2007, Genes and Immunity.
[121] M. Iannuzzi,et al. Epidemiology of Sarcoidosis: Recent Advances and Future Prospects , 2007, Seminars in respiratory and critical care medicine.
[122] M. Judson,et al. Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. , 2006, Clinics in chest medicine.
[123] P. Spagnolo,et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.
[124] R. Elston,et al. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. , 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[125] K. Huse,et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2 , 2005, Nature Genetics.
[126] E. Hafen,et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. , 2004, Genes & development.
[127] M. Iannuzzi,et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. , 2003, American journal of human genetics.
[128] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[129] S. Meloche,et al. Rho Family GTPases Are Required for Activation of Jak/STAT Signaling by G Protein-Coupled Receptors , 2003, Molecular and Cellular Biology.
[130] G. Thomas,et al. CARD15 mutations in Blau syndrome , 2001, Nature Genetics.
[131] K. Welsh,et al. Correspondence and requests for reprints should be addressed to Dr. Martin , 2022 .
[132] H. Inoko,et al. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. , 2000, Tissue antigens.
[133] K. Welsh,et al. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. , 1999, American journal of respiratory and critical care medicine.
[134] M. Iannuzzi. Genetics of sarcoidosis. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[135] B. Veress,et al. The distribution of S100 and lysozyme immunoreactive cells in the various phases of granuloma development in sarcoidosis. , 1987, Sarcoidosis.
[136] M. Yáñez,et al. An Update to Calcium Binding Proteins. , 2020, Advances in experimental medicine and biology.
[137] A. Wells,et al. Advanced sarcoidosis. , 2019, Current opinion in pulmonary medicine.
[138] D. Gritz,et al. Clinical Course of Sarcoidosis in World Trade Center‐Exposed Firefighters , 2018, Chest.
[139] Abbas Dehghan,et al. Genome-Wide Association Studies. , 2018, Methods in molecular biology.
[140] P. Rutgeerts,et al. Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. , 2016, The New England journal of medicine.
[141] Kumar Kshitij Patel,et al. Human genome meeting 2016 , 2016, Human Genomics.
[142] L. Platanias,et al. Intersection of mTOR and STAT signaling in immunity. , 2015, Trends in immunology.
[143] Y. Lee,et al. Associations between TNF-α −308 A/G and lymphotoxin-α +252 A/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis , 2013, Molecular Biology Reports.